Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury.Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injuryChondroitinase gene therapy improves upper limb function following cervical contusion injury
author
nationality
type
label
Nicholas D James
firstName
Nicholas D